These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2458584)

  • 1. Comparative analysis of growth factors in normal and pathologic human prostates.
    Nishi N; Matuo Y; Kunitomi K; Takenaka I; Usami M; Kotake T; Wada F
    Prostate; 1988; 13(1):39-48. PubMed ID: 2458584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin binding affinity of rat prostatic growth factor in normal and cancerous prostates: partial purification and characterization of rat prostatic growth factor in the Dunning tumor.
    Matuo Y; Nishi N; Matsui S; Sandberg AA; Isaacs JT; Wada F
    Cancer Res; 1987 Jan; 47(1):188-92. PubMed ID: 3791206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-binding growth factor isolated from human prostatic extracts.
    Mydlo JH; Bulbul MA; Richon VM; Heston WD; Fair WR
    Prostate; 1988; 12(4):343-55. PubMed ID: 3393496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human prostatic growth factor (hPGF): partial purification and characterization.
    Nishi N; Matuo Y; Muguruma Y; Yoshitake Y; Nishikawa K; Wada F
    Biochem Biophys Res Commun; 1985 Nov; 132(3):1103-9. PubMed ID: 2416312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA.
    Hierowski MT; McDonald MW; Dunn L; Sullivan JW
    J Urol; 1987 Oct; 138(4):909-12. PubMed ID: 2443730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors in the prostate.
    Matuo Y; Nishi N; Wada F
    Arch Androl; 1987; 19(3):193-210. PubMed ID: 2461175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate growth factor in the extracts of benign prostatic hypertrophy. Partial purification and physicochemical characterization.
    Jinno H; Ueda K; Otaguro K; Kato T; Ito J; Tanaka R
    Eur Urol; 1986; 12(1):41-8. PubMed ID: 2419135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification and characterization of a growth factor from human hyperplastic prostatic tissues.
    Dignass A; Holldorf AW
    Urol Res; 1992; 20(2):133-8. PubMed ID: 1372771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors.
    Mansson PE; Adams P; Kan M; McKeehan WL
    Cancer Res; 1989 May; 49(9):2485-94. PubMed ID: 2468410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A growth factor in extracts of human prostatic tissue.
    Lawson RK; Story MT; Jacobs SC
    Prog Clin Biol Res; 1981; 75A():325-36. PubMed ID: 6175979
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial purification of a prostatic growth factor.
    Story MT; Jacobs SC; Lawson RK
    J Urol; 1984 Dec; 132(6):1212-5. PubMed ID: 6209424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose.
    Hauschka PV; Mavrakos AE; Iafrati MD; Doleman SE; Klagsbrun M
    J Biol Chem; 1986 Sep; 261(27):12665-74. PubMed ID: 3745206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney.
    Mydlo JH; Heston WD; Fair WR
    J Urol; 1988 Dec; 140(6):1575-9. PubMed ID: 3193547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic factors in prostatic tissue and expressed prostatic secretion.
    Tackett RE; Heston WD; Parrish RF; Pletscher LS; Fair WR
    J Urol; 1985 Jan; 133(1):45-8. PubMed ID: 2578068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of heparin-binding growth factors from bovine, porcine and canine hearts.
    Quinkler W; Maasberg M; Bernotat-Danielowski S; Lüthe N; Sharma HS; Schaper W
    Eur J Biochem; 1989 Apr; 181(1):67-73. PubMed ID: 2714282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of heparin-binding growth factors from porcine uterus.
    Brigstock DR; Heap RB; Barker PJ; Brown KD
    Biochem J; 1990 Feb; 266(1):273-82. PubMed ID: 2310377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of subcellular proteins of normal prostate, benign prostatic hypertrophy, and prostatic cancer: presence of BPH-associated nonhistone proteins.
    Wada F; Nishi N; Tanaka Y; Muguruma Y; Tanaka K; Usami M; Kotake T; Matsui S; Sandberg AA; Matuo Y
    Prostate; 1985; 7(1):107-15. PubMed ID: 2417215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors.
    Rauvala H
    EMBO J; 1989 Oct; 8(10):2933-41. PubMed ID: 2583087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry.
    Schulze H; Claus S
    Prostate; 1990; 16(4):331-43. PubMed ID: 1695369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective osteoblast mitogens can be extracted from prostatic tissue.
    Koutsilieris M; Rabbani SA; Goltzman D
    Prostate; 1986; 9(2):109-15. PubMed ID: 2428019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.